TX-FLUENCE
15.6.2021 13:02:13 CEST | Business Wire | Press release
Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, today released its RAZR Modular System, the company’s newest LED solution for vertical farmers featuring market-leading efficacies of 2.6 µmol/J under Fluence’s PhysioSpec™ BROAD R3 white spectrum.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210615005453/en/
Fluence’s years of experience collaborating with vertical farmers have proven PhysioSpec™ BROAD R3 is the optimal spectrum choice for crop propagation and full-cycle cultivation for a multitude of leafy greens, microgreens, herbs and other vegetables. Under Fluence’s BROAD R3 spectrum, the newest RAZR system is 18% more efficient than previous generations. The RAZR Modular System’s mechanical mounting and electrical wiring are also highly configurable and easily integrate into various racking styles. The system’s flexible design makes it uniquely suited for scale in a vertical farming environment.
“Vertical farmers are fueling some of the greatest innovations in modern crop production,” said David Cohen, CEO of Fluence. “By simplifying the food supply chain, vertical farms can deliver fresh, nutritional produce to localized regions. These intricate cultivation facilities typically require custom, multilayer racking systems with specialized LED lighting solutions that can optimize plant development through various growth stages. Our RAZR Modular System not only reduces overall operational expenses through its efficient and configurable fixtures, but also offers a proven spectrum for propagation and vertical cultivation for leafy greens, microgreens, herbs and other vegetables.”
Fluence distributes its RAZR Modular System to vertical farmers directly and through partners such as Ecopromt, a leading greenhouse consultancy. Ecopromt’s cultivation experts have designed a fully integrated cart system featuring the RAZR Modular System as well as a proprietary irrigation system. Ecopromt’s integrated cart system has been installed in multiple vertical farms throughout Europe and the U.S.
“Our team has been designing, developing and growing under the most advanced cart systems for vertical farming for nearly a decade,” said Tom Jönsson, head of sales for Ecopromt. “Ecopromt’s fully integrated system is easy to install and built to scale as a vertical farm grows. Combined with our irrigation system and configurable design, RAZR’s modular capabilities provide homogenous light distribution across crops, enabling growers to produce consistent, high-quality plants under some of the industry’s most efficient lighting technology.”
Based in Brooklyn, New York, aquaponic vertical farm Upward Farms leverages Fluence’s RAZR Modular System to optimize growth cycles for several microgreen and baby green variants through different stages of cultivation.
“The RAZR system is flexible, efficient and powerful, which allowed us to quickly and seamlessly integrate it into our grow stacks,” said Ben Silverman, CTO of Upward Farms. “RAZR’s modular nature allows us to tailor the lights to our system while increasing efficiency and reducing grow time.”
For more information about the RAZR Modular System and Fluence’s extended portfolio of LED solutions, visit www.fluence.science .
About Fluence by OSRAM
Fluence Bioengineering, Inc., a wholly-owned subsidiary of OSRAM , creates powerful and energy-efficient LED lighting solutions for commercial crop production and research applications. Fluence is a leading LED lighting supplier in the global cannabis market and is committed to enabling more efficient crop production with the world’s top vertical farms and greenhouse produce growers. Fluence global headquarters are based in Austin, Texas, with its EMEA headquarters in Rotterdam, Netherlands. For more information about Fluence, visit https://fluence.science .
About Upward Farms
Upward Farms is a USDA-Certified Organic aquaponic vertical farm located in Brooklyn, NY. Upward Farms uses a breakthrough approach that marries modern vertical farming with the ancient practice of aquaponics. This method utilizes fish to fertilize crops in a complete ecosystem that relies on the naturally occurring microbiome, which is the superpower that has sustained life for millions of years. Upward Farms is dedicated to healing the broken food system & reconnecting eaters with flavorful, nutritious, local food. To learn more about Upward Farms, visit www.eatupwardfarms.com .
About Ecopromt
Ecopromt is a family-owned business that works in the horticulture sector, specialized in fresh herbs but also focuses on research and development on other crops. Ecopromt offers consultation on growing and technical advice, with a business strategy of combining biology, chemistry and automation so that growers around the world can get more effective with their crops. Ecopromt with its main office in Sweden is an official reseller of Fluence by OSRAM lights and manufacturer of our own integrated cart systems. Ecopromt also have a branch office in Harrisonburg, Virginia where we offer similar services.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210615005453/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vonage Expands Developer Ecosystem to Accelerate the Next Era of Enterprise Digital Transformation19.2.2026 10:08:00 CET | Press release
Vonage verified Postman workspace extends reach by 40+ million developers; MCP servers and Startup Program among resources designed to further accelerate time-to-value for developers and enterprises Vonage, part of Ericsson (NASDAQ: ERIC), today announced a number of new initiatives, to further expand and enable its global developer community. By growing its developer community and tools, giving developers and enterprises access to new mobile network insights and capabilities that can be embedded into existing applications and workflows, Vonage is accelerating its strategy to transform mobile networks into a programmable platform. Putting Vonage APIs in the Hands of 40 million+ More Developers Vonage is announcing the launch of its Verified Workspace on the Postman API Network, making Vonage APIs available to the 40+ million developers who use Postman. The new, verified workspace gives Postman’s community of global developer members certified access to Vonage’s portfolio of Network API
Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 202619.2.2026 08:50:00 CET | Press release
Brenus Pharma, a clinical-stage biotechnology company pioneering in vivo “off-the-shelf” immunotherapies, announced the selection of an abstract for a poster presentation at the American Association for Cancer Research Immuno-Oncology (AACRIO) annual conference (February 18-21, 2026), in Los Angeles. The poster showcases new preclinical data and early clinical insights from the company's lead candidate, STC-1010, supporting it as a promising therapeutic option for MSS, immune-cold colorectal cancer (CRC)—a major unmet clinical need. In a syngeneic CT26 model, murine STC-1010 significantly inhibits tumor growth and extends survival by 40%. New mechanistic datas reveal expansion of CD4⁺ and CD8⁺ T cells in draining lymph nodes alongside a significant humoral response compared to control, demonstrating coordinated cellular and humoral immune activation in vivo. Other findings show that dendritic cells efficiently capture STC-1010, leading to their activation as demonstrated by transcripto
ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer19.2.2026 08:30:00 CET | Press release
Based on DESTINY-Breast05 phase 3 trial results, which showed ENHERTU reduced the risk of invasive disease recurrence or death by 53% compared to T-DM1 If approved, Daiichi Sankyo and AstraZeneca’s ENHERTU has the potential to become a new standard of care in this early breast cancer setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® (trastuzumab deruxtecan) as a monotherapy for adult patients with HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer who have residual invasive disease after neoadjuvant HER2 targeted treatment. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committ
NHOA Energy Advances Delivery of the 51 MWh Broni Battery for Neoen in Italy19.2.2026 08:00:00 CET | Press release
The project confirms NHOA Energy’s long-term commitment to the Italian market NHOA Energy, global provider of utility-scale energy storage systems, is advancing the construction of the Broni Battery, a 10 MW/51 MWh project located in Broni (Pavia), Italy, executed for Neoen, one of the world’s leading independent producers of renewable energy. Civil works at the site are currently underway and advancing on schedule, with commissioning activities planned to start in late spring 2026. Once operational, the Broni Battery will provide essential flexibility services to the Italian electricity system, supporting grid stability and reliability as renewable energy penetration continues to increase. The project represents Neoen’s first battery storage asset in Italy and marks a strategic step in the company’s expansion, as it continues to grow its battery storage portfolio in key markets worldwide to support power system flexibility. The Broni Battery further strengthens NHOA Energy’s long-term
Compass Pathways Announces Pricing of $150 Million Public Offering19.2.2026 02:18:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the pricing of its public offering of 17,500,000 American Depositary Shares (“ADSs”) at a public offering price of $8.00 per ADS, each representing one ordinary share, and in lieu of ADSs, to certain institutional investors, pre-funded warrants to purchase up to 1,250,000 ADSs at a public offering price of $7.9999 per pre-funded warrant. In addition, Compass Pathways has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 ADSs at the public offering price, less the underwriting discounts and commissions. All of the securities are to be sold by Compass Pathways. The offering is expected to close on or about February 20, 2026, subject to the satisfaction of customary closing conditions. The gross proceeds to Compass Pathways from the offering, before deducting underwriting discounts and commissions and other est
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom